PROS1 and neoplasm: Additionally, PTC patients with tumor extrathyroidal extension had significantly lower PROS1, CLU, and LRG1 IHC scores compared to patients without extrathyroidal extension (P = .001, P = .001, and P = .001, respectively) (Tables 4–6).